Navigation Links
Phase 3 Trial of Aflibercept in Second-Line Metastatic Colorectal Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee
Date:9/8/2010

F Trap) with common chemotherapy regimens in several types of cancer.  In addition to VELOUR, the program includes two Phase 3 trials and one Phase 2 trial, all of which are fully enrolled:

  • VITAL study: 2nd-line treatment for metastatic non-small cell lung cancer in combination with docetaxel (Phase 3). Complete results are anticipated in the first half of 2011.  
  • VENICE study: 1st-line treatment for hormone-refractory metastatic prostate cancer (mHRPC) in combination with docetaxel and prednisone (Phase 3). An interim analysis is expected to be conducted by an IDMC in mid-2011, with complete results anticipated in 2012.
  • AFFIRM study: 1st-line treatment in mCRC in combination with folinic acid (leucovorin), 5-fluorouracil, and oxaliplatin (FOLFOX) (Phase 2).  Results are anticipated in 2H 2011.

  • About Aflibercept Aflibercept (VEGF Trap) is an anti-angiogenesis inhibitor with a unique mechanism of action.  This fusion protein binds all forms of Vascular Endothelial Growth Factor-A (VEGF-A), as well as VEGF-B and placental growth factor (PIGF), additional angiogenic growth factors that appear to play a role in tumor angiogenesis and inflammation. Aflibercept has been shown to bind VEGF-A, VEGF-B, and PlGF with higher affinity than their natural receptors.

    About Colorectal Cancer Worldwide, colorectal cancer is the third most common cancer in men and the second in women; accounting for about 8% of all cancer deaths, making it the fourth most common cause of death from cancer.  Colorectal cancer disproportionately affects people over age 65.  FOLFIRI (5-fluorouracil, leucovorin, and irinotecan) is considered a standard backbone of second-line treatment in patients with advanced metastatic colorectal cancer.

    About sanofi-aventis OncologySanofi-aventis Oncology is targeting cancer on all fronts in an effort to address unmet medical needs for a broad range of patie
    '/>"/>

    SOURCE Regeneron Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
    3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
    4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
    5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
    7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
    8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
    9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
    10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
    11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/27/2015)... 27, 2015 As of February, InControl ... devices for women. "Shipping thousands of ... part is the hundreds of letters, emails and ... have been positively impacted by our technology," said ... InControl recently released Apex, an over-the-counter solution ...
    (Date:3/27/2015)... BRUNSWICK, N.J. , March 27, 2015  Johnson & ... of Shareholders at 10 a.m. (Eastern Time) on Thursday, April ... Brunswick, N.J. Investors and other interested ... by visiting the Company,s website at www.jnj.com and ... presentations from the meeting will be made available a few ...
    (Date:3/27/2015)... 27, 2015  WebMD Health Corp. (NASDAQ: ... health information, today announced an exclusive White ... Action Plan for Combating Antibiotic-Resistant Bacteria . ... urgency and importance of addressing antibiotic-resistant bacteria ... health.    The WebMD interview, available ...
    Breaking Medicine Technology:InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3
    ... ROCKLAND, Mass. , July 28 EMD Serono, Inc., ... the U.S. Food and Drug Administration (FDA) has accepted for filing the ... forms of multiple sclerosis (MS). , ... The application also has been granted a Priority Review designation by ...
    ... SHANGHAI , July 27 /PRNewswire-Asia/ -- ... that RiskMetrics Group,s ISS Proxy Advisory Services,("ISS"), a leading independent ... shareholders vote FOR Charles River,s proposed,acquisition of WuXi. Two other ... WuXi shareholders vote FOR the,transaction. , ...
    Cached Medicine Technology:EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS 2EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS 3EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS 4EMD Serono, Inc.: FDA Grants Priority Review to Cladribine Tablets for the Treatment of Relapsing Forms of MS 5ISS Recommends That WuXi Shareholders Vote for Proposed Combination With Charles River 2ISS Recommends That WuXi Shareholders Vote for Proposed Combination With Charles River 3ISS Recommends That WuXi Shareholders Vote for Proposed Combination With Charles River 4ISS Recommends That WuXi Shareholders Vote for Proposed Combination With Charles River 5
    (Date:3/28/2015)... New York (PRWEB) March 28, 2015 ... ) involving devices manufactured by C.R. Bard, Inc. ... underway in U.S. District Court, Southern District of ... Grand, is serving on the Plaintiffs’ Steering Committee. ... the Court has granted certain defendants named in ...
    (Date:3/28/2015)... March 28, 2015 Emergency Medical Care ... care in Manhattan, recently commemorated its three-year anniversary of ... Manhattan. In addition to 24-hour urgent care, Emergency Medical ... , At this time, Emergency Medical Care’s Urgent ... asthma, chest pain, eye injuries, ear infections, fevers, insect ...
    (Date:3/28/2015)... 2015 An article in Fortune on ... prove critical to organizations that deal with PCI (Payment ... of data security, is worsening . Using numbers ... every major category out of the twelve measured improved, ... all the craziness that has gone on in the ...
    (Date:3/28/2015)... Pitching speed, player’s height, and pitching for multiple teams ... according to new research released today at the American Orthopaedic ... “Our findings indicate that a 10 inch increase in height ... history of injury, a 10 mile per hour increase in ... history of injury, and playing for more than one team ...
    (Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... hip injuries is a growing field in orthopaedic medicine. ... with labral tear to confirm the pain etiology, research ... Medicine’s ( AOSSM ) Specialty Day suggests that pain ... outcomes following arthroscopic hip surgery. , “Our study ...
    Breaking Medicine News(10 mins):Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 2Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 3Health News:Federal C.R. Bard Vaginal Mesh Lawsuits Move Forward, As Court Grants Defense Motion to Amend Responses to Master Complaint 4Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 2Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 3Health News:Businesses Dealing With PCI Falling Short On Regular Vulnerability Scans and Pen Testing 4Health News:Researchers Highlight Shoulder and Elbow Injury Possibility in Youth Players 2Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2
    ... Oct. 4 Hooper Holmes,(Amex: HH ) ... training,program for all paramedical examiners who have not ... training system,will be rolled out in November with ... same high quality education and training from the ...
    ... Calif., Oct. 4 Onyx,Pharmaceuticals, Inc. (Nasdaq: ONXX ... executive officer, plans to retire next year.,Renton, 60, will ... result of,his decision, the company is initiating a search ... Laura A. Brege to the newly created,position of executive ...
    ... DIEGO, Oct. 4 /PRNewswire/ As the festive holiday season ... with,often-unrealistic demands and expectations of family, friends and events.,The ... take good care of,ourselves, which in turn will increase ... this season, ACE offers 10 tips for surviving the,holidays. ...
    ... Confectioner,s,Association has noted that up to 93% of ... mind, Halloween is a perfect time for parents ... "Since candy and Halloween go together...Consider being somewhat,lenient ... chocolate and,lollipops on occasion as long as they ...
    ... Extends Battery,Life Up To 10 Years; Enables Energy Savings and Efficiency ... ... Endusers, HOUSTON, Oct. 3 ISA EXPO Booth# 1978 -- ... network solution that utilizes the widely deployed Wi-Fi,infrastructure while providing years ...
    ... WASHINGTON, Oct. 3 - Speaker Nancy Pelosi,issued the following ... Insurance Program legislation:, "Today the President had an ... care to 10 million children in families struggling to,make ... pen to say ,I,forbid 10 million children from getting ...
    Cached Medicine News:Health News:Portamedic Launches New Examiner Training Program 2Health News:Portamedic Launches New Examiner Training Program 3Health News:Onyx Pharmaceuticals Announces Management Changes 2Health News:Onyx Pharmaceuticals Announces Management Changes 3Health News:American Council on Exercise Offers 10 Tips for Surviving the Holidays 2Health News:Parents can Help Young Superheroes Battle Cavities on Halloween Night 2Health News:GainSpan Unveils Wi-Fi(R) Sensor Network Solution With Years of Battery Life 2Health News:GainSpan Unveils Wi-Fi(R) Sensor Network Solution With Years of Battery Life 3Health News:GainSpan Unveils Wi-Fi(R) Sensor Network Solution With Years of Battery Life 4Health News:GainSpan Unveils Wi-Fi(R) Sensor Network Solution With Years of Battery Life 5
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 10 mm....
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 7.0 mm and length 7.7 mm....
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 6.0 mm and length 10 mm....
    Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 9.0 mm and length 7.5 mm....
    Medicine Products: